Company / Total Assets
Kura Oncology, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$738.4M
FY2025
5-year range
$448.9M / $760.2M
FY2021-FY2025
Trend
-2.9%
vs FY2024
Sector context
#104 of 214
Health Care
What the data says
At $738M, Kura Oncology, Inc.'s total assets ranks #104 of 214 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $70M in FY2016 to $760M in FY2024.
Based on SEC 10-K filings.
$738M in FY2025 with a 5-year CAGR of +2.7%.
Improved from $449M to $738M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +17.4%
- 5-Year CAGR
- +2.7%
- 10-Year CAGR
- -
Sector benchmark
#104 of 214 in Health CareTop 49% of 214This company $738.4M Sector average $7.5B
▼
-90.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.7%, indicating consistent growth.
- In FY2025, total assets decreased 2.9% year-over-year.
- Ranks #104 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $738.4M | -2.9% |
| FY2024 | $760.2M | +69.3% |
| FY2023 | $448.9M | -1.6% |
| FY2022 | $456.3M | -14.6% |
| FY2021 | $534.1M | -17.5% |
| FY2020 | $647.2M | +167.5% |
| FY2019 | $242.0M | +32.7% |
| FY2018 | $182.4M | +90.3% |
| FY2017 | $95.9M | +37.3% |
| FY2016 | $69.8M | -20.0% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026